A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response.
The bill’s titles are written by its sponsor.
Feb 12, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on February 12, 2015, in a previous session of Congress, but was not enacted.
Senior Senator from Kansas
Read Text »
Last Updated: Feb 12, 2015
Length: 3 pages
Jan 24, 2013
Earlier Version — Introduced
This activity took place on a related bill, S. 133 (113th).
Feb 12, 2015
S. 484 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2017). S. 484 — 114th Congress: PATIENTS Act of 2015. Retrieved from https://www.govtrack.us/congress/bills/114/s484
“S. 484 — 114th Congress: PATIENTS Act of 2015.” www.GovTrack.us. 2015. September 26, 2017 <https://www.govtrack.us/congress/bills/114/s484>
|title=S. 484 (114th)
|accessdate=September 26, 2017
|author=114th Congress (2015)
|date=February 12, 2015
|quote=PATIENTS Act of 2015